1454907-27-7

Basic information

• Product Name: N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide
• Synonyms: N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide
• CAS NO: 1454907-27-7
• Molecular Weight: 392.454
• Mol File: 1454907-27-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide(1454907-27-7)
• EPA Substance Registry System: N-{7-[4-((1R,2S)-2-amino-3-fluoro-1-hydroxypropyl)phenyl]imidazo[1,2-a]pyridin-2-ylmethyl}methanesulfonamide(1454907-27-7)

Safety Data

• Hazardous Substances Data: 1454907-27-7(Hazardous Substances Data)

Upstream product

• 1454907-26-6 (4S,5R)-4-fluoromethyl-5-{4-[2-(methanesulfonylaminomethyl)imidazo[1,2-a]pyridin-7-yl]phenyl}-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 1454907-25-5 N-(7-bromoimidazo[1,2-a]pyridin-2-ylmethyl)methane sulfonamide 
• 886371-82-0 C-(7-bromoimidazo[1,2-a]pyridin-2-yl)methylamine 
• 1019023-07-4 7-bromo-2-chloromethylimidazo[1,2-a]pyridine 
• 1187236-21-0 (7-bromoimidazo[1,2-a]pyridin-2-yl)methanol 
• 1187236-18-5 7-bromoimidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester 
• 84249-14-9 2-amino-4-bromopyridine 
• 1382801-14-0 (4S,5R)-4-fluoromethyl-2,2-dimethyl-5-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)phenyl]oxazolidine-3-carboxylic acid tert-butyl ester 
• 1454906-58-1 (4S,5R)-4-fluoromethyl-5-(4-iodophenyl)-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 1052114-46-1 tert-butyl ((1R,2S)-3-fluoro-1-hydroxy-1-(4-iodophenyl)propan-2-yl)carbamate 

Relevant articles and documents

PHENICOL ANTIBACTERIALS

The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.